Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V: Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006, 295: 2275-2285. 10.1001/jama.295.19.2275.
Article
CAS
PubMed
Google Scholar
Bradley JR: TNF-mediated inflammatory disease. J Pathol. 2008, 214: 149-160. 10.1002/path.2287.
Article
CAS
PubMed
Google Scholar
Ravelli A, Martini A: Juvenile idiopathic arthritis. Lancet. 2007, 369: 767-778. 10.1016/S0140-6736(07)60363-8.
Article
CAS
PubMed
Google Scholar
Foster H, Rapley T, May C: Juvenile idiopathic arthritis: improved outcome requires improved access to care. Rheumatol. 2010, 49: 401-3. 10.1093/rheumatology/kep347.
Article
Google Scholar
Horneff G, Schmeling H, Biedermann T, Foeldvari I, Ganser G, Girschick HJ, Hospach T, Huppertz HI, Keitzer R, Küster RM, Michels H, Moebius D, Rogalski B, Thon A, Paediatric Rheumatology Collaborative Group: The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis. 2004, 63: 1638-1644. 10.1136/ard.2003.014886.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, Baumgartner SW, Giannini EH, Pediatric Rheumatology Collaborative Study G: Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum. 2008, 58: 1496-1504. 10.1002/art.23427.
Article
CAS
PubMed
Google Scholar
Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, Nemcova D, Mouy R, Sandborg C, Bohnsack J, Elewaut D, Foeldvari I, Gerloni V, Rovensky J, Minden K, Vehe RK, Weiner LW, Horneff G, Huppertz HI, Olson NY, Medich JR, Carcereri-De-Prati R, McIlraith MJ, Giannini EH, Martini A, Pediatric Rheumatology Collaborative Study Group; Pediatric Rheumatology International Trials Organisation: Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med. 2008, 359: 810-820. 10.1056/NEJMoa0706290.
Article
CAS
PubMed
Google Scholar
Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S, Beutler A, Keenan G, Clark J, Visvanathan S, Fasanmade A, Raychaudhuri A, Mendelsohn A, Martini A, Giannini EH, Paediatric Rheumatology International Trials Organisation; Pediatric Rheumatology Collaborative Study Group: A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 2007, 56: 3096-3106. 10.1002/art.22838.
Article
CAS
PubMed
Google Scholar
Ruperto N, Lovell DJ, Cuttica R, Woo P, Meiorin S, Wouters C, Silverman ED, Balogh Z, Henrickson M, Davidson J, Foeldvari I, Imundo L, Simonini G, Oppermann J, Xu S, Shen YK, Visvanathan S, Fasanmade A, Mendelsohn A, Martini A, Giannini EH, Paediatric Rheumatology INternational Trials Organization (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG): Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Ann Rheum Dis. 2010, 69: 718-722. 10.1136/ard.2009.100354.
Article
PubMed Central
CAS
PubMed
Google Scholar
Enbrel (etanercept) US Prescribing Information. [http://www.enbrel.com/prescribing-information.jsp]
Humira (adalimumab) Prescribing Information. [http://www.rxabbott.com/pdf/humira.pdf]
Remicade (infliximab) Prescribing Information. [http://www.remicade.com/remicade/assets/HCP_PPI.pdf]
Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, Bertilsson L, Cöster L, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, van Vollenhoven R, Klareskog L, Feltelius N: Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis. 2009, 68: 648-653. 10.1136/ard.2007.085852.
Article
CAS
PubMed
Google Scholar
Askling J, Bongartz T: Malignancy and biologic therapy in rheumatoid arthritis. Curr Opin Rheumatol. 2008, 20: 334-339. 10.1097/BOR.0b013e3282f7c706.
Article
CAS
PubMed
Google Scholar
Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, Sundström C, Bertilsson L, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, Klareskog L, Feltelius N: Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis. 2005, 64: 1414-1420. 10.1136/ard.2004.033241.
Article
PubMed Central
CAS
PubMed
Google Scholar
Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, Klareskog L: Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis. 2005, 64: 1421-1426. 10.1136/ard.2004.033993.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bongartz T, Warren FC, Mines D, Matteson EL, Abrams KR, Sutton AJ: Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials. Ann Rheum Dis. 2009, 68: 1177-1183. 10.1136/ard.2008.094904.
Article
CAS
PubMed
Google Scholar
Zink A, Askling J, Dixon WG, Klareskog L, Silman AJ, Symmons DPM: European biologicals registers: methodology, selected results and perspectives. Ann Rheum Dis. 2009, 68: 1240-1246. 10.1136/ard.2008.091926.
Article
CAS
PubMed
Google Scholar
Londino AV, Blatt J, Knisely AS: Hodgkin's disease in a patient with juvenile rheumatoid arthritis taking weekly low dose methotrexate. J Rheumatol. 1998, 25: 1245-1246.
PubMed
Google Scholar
Yildirim-Toruner C, Kimura Y, Rabinovich E: Hodgkin's lymphoma and tumor necrosis factor inhibitors in juvenile idiopathic arthritis. J Rheumatol. 2008, 35: 1680-1681.
PubMed
Google Scholar
Advani AS, Hunger SP, Burnett AK: Acute Leukemia in Adolescents and Young Adults. Semin Oncol. 2009, 36: 213-226. 10.1053/j.seminoncol.2009.03.007.
Article
CAS
PubMed
Google Scholar
Jaglowski SM, Linden E, Termuhlen AM, Flynn JM: Lymphoma in Adolescents and Young Adults. Semin Oncol. 2009, 36: 381-418. 10.1053/j.seminoncol.2009.07.009.
Article
CAS
PubMed
Google Scholar
Surveillance, Epidemiology, and End Results (SEER) Program. [http://www.seer.cancer.gov/]
Imundo L: Hodgkin's lymphoma associated with anti-TNF use in juvenile idiopathic arthritis: supplemental case report. J Rheumatol. 2008, 35: 1681-
PubMed
Google Scholar
Baker GL, Kahl LE, Zee BC, Stolzer BL, Agarwal AK, Medsger TA: Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study. Am J Med. 1987, 83: 1-9. 10.1016/0002-9343(87)90490-6.
Article
CAS
PubMed
Google Scholar
Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD: Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut. 2005, 54: 1121-1125. 10.1136/gut.2004.049460.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bradlow A, Barton C: Arthritic presentation of childhood leukaemia. Postgrad Med J. 1991, 67: 562-564. 10.1136/pgmj.67.788.562.
Article
PubMed Central
CAS
PubMed
Google Scholar
Cabral DA, Tucker LB: Malignancies in children who initially present with rheumatic complaints. J Pediatrics. 1999, 134: 53-57. 10.1016/S0022-3476(99)70372-0.
Article
CAS
Google Scholar
Murray MJ, Tang T, Ryder C, Mabin D, Nicholson JC: Childhood leukaemia masquerading as juvenile idiopathic arthritis. BMJ. 2004, 329: 959-961. 10.1136/bmj.329.7472.959.
Article
PubMed Central
CAS
PubMed
Google Scholar
Marwaha RK, Kulkarni KP, Bansal D, Trehan A: Acute lymphoblastic leukemia masquerading as juvenile rheumatoid arthritis: diagnostic pitfall and association with survival. Ann Hematol. 2010, 89: 249-54. 10.1007/s00277-009-0826-3. Epub 2009 Sep 2
Article
CAS
PubMed
Google Scholar
Tafaghodi F, Aghighi Y, Yazdi HR, Shakiba M, Adibi A: Predictive plain X-ray findings in distinguishing early stage acute lymphoblastic leukemia from juvenile idiopathic arthritis. Clin Rheumatol. 2009, 28: 1253-1258. 10.1007/s10067-009-1221-0.
Article
PubMed
Google Scholar
Askling J, Brandt L, Lapidus A, Karlen P, Bjorkholm M, Lofberg R, Ekbom A: Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut. 2005, 54: 617-622. 10.1136/gut.2004.051771.
Article
PubMed Central
CAS
PubMed
Google Scholar
Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundstrom C, Klareskog L: Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006, 54: 692-701. 10.1002/art.21675.
Article
PubMed
Google Scholar
Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH: Rheumatoid arthritis and cancer risk. Eur J Cancer. 1996, 32A: 1753-1757. 10.1016/0959-8049(96)00210-9.
Article
CAS
PubMed
Google Scholar
Thomas E, Brewster DH, Black RJ, Macfarlane GJ: Risk of malignancy among patients with rheumatic conditions. Int J Cancer. 2000, 88: 497-502. 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J.
Article
CAS
PubMed
Google Scholar
Pallavicini FB, Caporali R, Sarzi-Puttini P, Atzeni F, Bazzani C, Gorla R, Marchesoni A, Favalli EG, Montecucco C: Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registry. Autoimmun Rev. 2010, 9: 175-180. 10.1016/j.autrev.2009.07.006.
Article
PubMed
Google Scholar
Geborek P, Bladstrom A, Turesson C, Gulfe A, Petersson IF, Saxne T, Olsson H, Jacobsson LT: Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis. 2005, 64: 699-703. 10.1136/ard.2004.030528.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wolfe F, Michaud K: The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum. 2007, 56: 1433-1439. 10.1002/art.22579.
Article
CAS
PubMed
Google Scholar
Wolfe F, Michaud K: Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum. 2007, 56: 2886-2895. 10.1002/art.22864.
Article
PubMed
Google Scholar
Kaiser R: Incidence of lymphoma in patients with rheumatoid arthritis: A systematic review of the literature. Clin Lymphoma Myeloma. 2008, 8: 87-93. 10.3816/CLM.2008.n.009.
Article
PubMed
Google Scholar
Mariette X, Tubach F, Bagheri H, Bardet M, Berthelot JM, Gaudin P, Heresbach D, Martin A, Schaeverbeke T, Salmon D, Lemann M, Hermine O, Raphael M, Ravaud P: Lymphoma in patients treated with anti-TNF. Results of the 3-year prospective French RATIO registry. Ann Rheum Dis. 2010, 69: 400-408. 10.1136/ard.2009.117762.
Article
PubMed Central
CAS
PubMed
Google Scholar
Simard JF, Neovius M, Hagelberg S, Askling J: Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study. EULAR. Rome, Italy; 2010. Abstract # OP0086. Available at Accessed June 10, 2010, [https://b-com.mci-group.com/AbstractList/EULAR10.aspx]
Padeh S, Sharon N, Schiby G, Rechavi G, Passwell JH: Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate. J Rheumatol. 1997, 24: 2035-2037.
CAS
PubMed
Google Scholar
Bes C, Bes Z, Vardı Ş, Soy M: Anaplastic large cell lymphoma in a patient with rheumatoid arthritis. Rheumatol Int.
Sokol H, Beaugerie L: Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle. Gut. 2009, 58: 1427-1436. 10.1136/gut.2009.181982.
Article
CAS
PubMed
Google Scholar
Rosh JR, Gross T, Mamula P, Griffiths A, Hyams J: Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?. Inflamm Bowel Dis. 2007, 13: 1024-1030. 10.1002/ibd.20169.
Article
PubMed
Google Scholar